» Articles » PMID: 21723900

Antigen Encoded by Vaccine Vectors Derived from Human Adenovirus Serotype 5 is Preferentially Presented to CD8+ T Lymphocytes by the CD8α+ Dendritic Cell Subset

Overview
Journal Vaccine
Date 2011 Jul 5
PMID 21723900
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

Different subsets of dendritic cells (DC) elicit qualitatively different immune responses. In mice, two lymphoid tissue-resident subsets, CD8α(+) and CD8α(-), have been implicated in the induction of T helper 1 (Th1) or Th2 responses, respectively. Moreover, CD8α(+) DC appear to play a major role in priming CD8(+) T lymphocyte responses to viral antigens in the course of diverse viral infections. These considerations have been less extensively explored for vaccine vectors derived from viruses. Despite inefficient ex vivo transduction of DC, vectored vaccines derived from human adenoviruses of serotype 5 (Ad5) elicit robust immune responses, predominantly of the Th1 orientation, in humans and mice. At present it is unknown whether Ad5 interacts with DC subsets in a differential manner, thereby influencing the quality of the elicited IR. To address this issue, successive steps (attachment, transgene expression, MHC class I antigen presentation and activation of antigen-specific T lymphocytes) involved in induction of immune responses by Ad5-based vectors have been examined in CD8α(+) and CD8α(-) murine DC subsets. Although in both ex vivo and in vivo experiments CD8α(+) and CD8α(-) DC subsets captured an Ad5-based vector to a similar extent, transgene expression and subsequent MHC class I display of a transgene-encoded antigen were more efficient in CD8α(+) DC. Moreover, following in vivo and ex vivo transduction with an Ad5-based vaccine, antigen-specific CD8(+) T lymphocytes were more efficiently activated by CD8α(+) DC than by CD8α(-) DC. Thus, superior antigen expression and MHC class I display in CD8α(+) DC may contribute to preferred priming of antigen-specific CD8(+) lymphocytes by Ad5-transduced CD8α(+) DC.

Citing Articles

Nanoparticle-Based Adjuvants and Delivery Systems for Modern Vaccines.

Filipic B, Pantelic I, Nikolic I, Majhen D, Stojic-Vukanic Z, Savic S Vaccines (Basel). 2023; 11(7).

PMID: 37514991 PMC: 10385383. DOI: 10.3390/vaccines11071172.


Evaluation of the immunogenicity of prime-boost vaccination with the replication-deficient viral vectored COVID-19 vaccine candidate ChAdOx1 nCoV-19.

Graham S, McLean R, Spencer A, Belij-Rammerstorfer S, Wright D, Ulaszewska M NPJ Vaccines. 2020; 5(1):69.

PMID: 32793398 PMC: 7385486. DOI: 10.1038/s41541-020-00221-3.


Firewalls Prevent Systemic Dissemination of Vectors Derived from Human Adenovirus Type 5 and Suppress Production of Transgene-Encoded Antigen in a Murine Model of Oral Vaccination.

Revaud J, Unterfinger Y, Rol N, Suleman M, Shaw J, Galea S Front Cell Infect Microbiol. 2018; 8:6.

PMID: 29423380 PMC: 5788964. DOI: 10.3389/fcimb.2018.00006.


Vaccination with recombinant adenovirus expressing peste des petits ruminants virus-F or -H proteins elicits T cell responses to epitopes that arises during PPRV infection.

Rojas J, Avia M, Pascual E, Sevilla N, Martin V Vet Res. 2017; 48(1):79.

PMID: 29157291 PMC: 5697415. DOI: 10.1186/s13567-017-0482-x.


Recall T cell responses to bluetongue virus produce a narrowing of the T cell repertoire.

Rojas J, Rodriguez-Calvo T, Sevilla N Vet Res. 2017; 48(1):38.

PMID: 28662714 PMC: 5492282. DOI: 10.1186/s13567-017-0444-3.